PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
PCI Biotech to present at DNB Nordic Healthcare Conference 2021
Guest UserDecember 14, 2021
PCI Biotech: Independent Data Monitoring Committee recommends continuation of two treatments in the RELEASE trial
Guest UserDecember 13, 2021
PCI Biotech: Update on regulatory interactions for the RELEASE trial
Guest UserDecember 7, 2021
PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments
Guest UserNovember 30, 2021
PCI Biotech to present at ABGSC Nordic Rare Disease Seminar
Guest UserNovember 29, 2021
PCI Biotech Q3 2021 interim results
Guest UserNovember 17, 2021
PCI Biotech: Invitation to Q3 2021 result presentation
Guest UserNovember 9, 2021
PCI Biotech to present at the 9th International mRNA Health Conference
Guest UserNovember 9, 2021
PCI Biotech: Presentation of fimaCHEM for bile duct cancer at IPA masterclass series
Guest UserNovember 8, 2021
PCI Biotech: Employee share option scheme
Guest UserSeptember 6, 2021
Financial calendar for PCI Biotech Holding ASA
Guest UserAugust 31, 2021
PCI Biotech first half-year 2021 interim results
Guest UserAugust 31, 2021
PCI Biotech: Invitation to first half-year 2021 result presentation
Guest UserAugust 23, 2021
PCI Biotech: US patent for the vaccine technology (fimaVACC) in combination with checkpoint inhibitors
Guest UserMay 31, 2021
PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer
Guest UserMay 28, 2021
Minutes from Annual General Meeting 2021
Guest UserMay 28, 2021
PCI Biotech is seeking a Scientific Alliance and Business Development Manager
Guest UserMay 11, 2021
Notice of Annual General Meeting 2021
Guest UserMay 7, 2021
PCI Biotech first quarter 2021 interim results
Guest UserMay 7, 2021
OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies
Guest UserMay 5, 2021
Newer Older

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED